Literature DB >> 11331277

Binding of low density lipoproteins to lipoprotein lipase is dependent on lipids but not on apolipoprotein B.

J Boren1, A Lookene, E Makoveichuk, S Xiang, M Gustafsson, H Liu, P Talmud, G Olivecrona.   

Abstract

Lipoprotein lipase (LPL) efficiently mediates the binding of lipoprotein particles to lipoprotein receptors and to proteoglycans at cell surfaces and in the extracellular matrix. It has been proposed that LPL increases the retention of atherogenic lipoproteins in the vessel wall and mediates the uptake of lipoproteins in cells, thereby promoting lipid accumulation and plaque formation. We investigated the interaction between LPL and low density lipoproteins (LDLs) with special reference to the protein-protein interaction between LPL and apolipoprotein B (apoB). Chemical modification of lysines and arginines in apoB or mutation of its main proteoglycan binding site did not abolish the interaction of LDL with LPL as shown by surface plasmon resonance (SPR) and by experiments with THP-I macrophages. Recombinant LDL with either apoB100 or apoB48 bound with similar affinity. In contrast, partial delipidation of LDL markedly decreased binding to LPL. In cell culture experiments, phosphatidylcholine-containing liposomes competed efficiently with LDL for binding to LPL. Each LDL particle bound several (up to 15) LPL dimers as determined by SPR and by experiments with THP-I macrophages. A recombinant NH(2)-terminal fragment of apoB (apoB17) bound with low affinity to LPL as shown by SPR, but this interaction was completely abolished by partial delipidation of apoB17. We conclude that the LPL-apoB interaction is not significant in bridging LDL to cell surfaces and matrix components; the main interaction is between LPL and the LDL lipids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331277     DOI: 10.1074/jbc.M011090200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 2.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

3.  We FRET so You Don't Have To: New Models of the Lipoprotein Lipase Dimer.

Authors:  Cassandra K Hayne; Hayretin Yumerefendi; Lin Cao; Jacob W Gauer; Michael J Lafferty; Brian Kuhlman; Dorothy A Erie; Saskia B Neher
Journal:  Biochemistry       Date:  2018-01-05       Impact factor: 3.162

4.  Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.

Authors:  Simon Bissonnette; Huda Salem; Hanny Wassef; Nathalie Saint-Pierre; Annie Tardif; Alexis Baass; Robert Dufour; May Faraj
Journal:  J Lipid Res       Date:  2013-02-17       Impact factor: 5.922

5.  Acrolein consumption induces systemic dyslipidemia and lipoprotein modification.

Authors:  Daniel J Conklin; Oleg A Barski; Jean-Francois Lesgards; Peter Juvan; Tadeja Rezen; Damjana Rozman; Russell A Prough; Elena Vladykovskaya; SiQi Liu; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-23       Impact factor: 4.219

6.  Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.

Authors:  Patrick Maillard; Marine Walic; Philip Meuleman; Farzin Roohvand; Thierry Huby; Wilfried Le Goff; Geert Leroux-Roels; Eve-Isabelle Pécheur; Agata Budkowska
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

7.  Intimal hyperplasia induced by vascular intervention causes lipoprotein retention and accelerated atherosclerosis.

Authors:  Siavash Kijani; Ana Maria Vázquez; Malin Levin; Jan Borén; Per Fogelstrand
Journal:  Physiol Rep       Date:  2017-07

8.  Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins.

Authors:  Shigeki Kamitani; Katsutoshi Yamada; Shigenori Yamamoto; Yoshikazu Ishimoto; Takashi Ono; Akihiko Saiga; Kohji Hanasaki
Journal:  Cell Mol Biol Lett       Date:  2012-06-13       Impact factor: 5.787

9.  Macrophages take up VLDL-sized emulsion particles through caveolae-mediated endocytosis and excrete part of the internalized triglycerides as fatty acids.

Authors:  Lei Deng; Frank Vrieling; Rinke Stienstra; Guido J Hooiveld; Anouk L Feitsma; Sander Kersten
Journal:  PLoS Biol       Date:  2022-08-26       Impact factor: 9.593

Review 10.  Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.

Authors:  Sven-Olof Olofsson; Olov Wiklund; Jan Borén
Journal:  Vasc Health Risk Manag       Date:  2007
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.